Literature DB >> 15130752

Histone deacetylases, HDAC1 and HSIR2, act as a negative regulator of ageing through p53 in human gingival fibroblast.

Moon-Moo Kim1, Sang-Oh Yoon, Yee Sook Cho, An-Sik Chung.   

Abstract

Histone deacetylases (HDACs) such as HDAC1 and HSIR2 have been known to be involved in the regulation of life-span extension. However, its underlying mechanism remains unclear in human. Using the primary human gingival fibroblasts (HGFs) derived from donors of different ages, which exhibit clear features of senescence in aged HGFs, we demonstrated that histone deacetylase, HDAC1 and HSIR2, repressed the ageing through the transcriptional inactivation of p53 and p21 promoters. These results suggest that primary HGFs can be a useful human ageing model, and HDAC1, HSIR2, p53 and p21 may play an important role in ageing process of human beings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15130752     DOI: 10.1016/j.mad.2004.01.010

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  4 in total

1.  Tenocyte apoptosis in the torn rotator cuff: a primary or secondary pathological event?

Authors:  Kirsten Lundgreen; Oystein Bjerkestrand Lian; Lars Engebretsen; Alex Scott
Journal:  Br J Sports Med       Date:  2011-04-10       Impact factor: 13.800

2.  Effect of curcumin on aged Drosophila melanogaster: a pathway prediction analysis.

Authors:  Zhi-guo Zhang; Xu-yan Niu; Ai-ping Lu; Gary Guishan Xiao
Journal:  Chin J Integr Med       Date:  2013-10-23       Impact factor: 1.978

Review 3.  Antagonistic pleiotropy and p53.

Authors:  Erica Ungewitter; Heidi Scrable
Journal:  Mech Ageing Dev       Date:  2008-07-01       Impact factor: 5.432

4.  Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis.

Authors:  Tomoko Kawabata; Keiichiro Nishida; Koji Takasugi; Hiroko Ogawa; Kenei Sada; Yasutaka Kadota; Junko Inagaki; Satoshi Hirohata; Yoshifumi Ninomiya; Hirofumi Makino
Journal:  Arthritis Res Ther       Date:  2010-07-07       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.